Countable Labs raises $26 million to develop advanced single-molecule PCR tools, expanding precision diagnostics for global ...

Countable Labs raises $26 million. Company shares plans for new products to support clinical testing applications and announces hire of sales leader.

Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.

According to WHO, it can be difficult to clinically distinguish Ebola disease from other infectious diseases such as malaria, ...

NIMS Hyderabad has launched Telangana’s first government-sector Next Generation Sequencing cancer testing facility. Established under the DIAMOnDS project, the centre offers advanced molecular ...

It's quick to spot a tick, but harder to know if that tick carries Lyme disease. Emergency room visits for tick bites provide important data for the Centers for Disease Control and Prevention, but ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

According to the experts, the Altona RT-PCR kit is the real star and is highly standardized. It rarely misses Ebola cases ...

Global health emergencies are shifting sovereign biodefense strategies toward decentralized diagnostic networks capable of deploying rapid stockpiles.

India’s first suspected Ebola case tested negative as authorities intensified airport screening, airline SOPs and ...

As tick populations rise across the country, concerns regarding Lyme disease increase every year. However, it is important to ...

This article is authored by Dr Kuldeep Singh Sachdeva, president and chief medical officer, Partnerships and Advocacy, Molbio ...